Large-scale testing (Phase 3)Ended earlyNCT01006252What this trial is testingTasisulam-sodium Versus Paclitaxel as Treatment for Metastatic MelanomaWho this might be right forMelanoma Eli Lilly and Company 336
Testing effectiveness (Phase 2)Study completedNCT03200847What this trial is testingPembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced MelanomaWho this might be right forStage IV MelanomaStage III MelanomaAdvanced Melanoma University of Colorado, Denver 26
Testing effectiveness (Phase 2)Ended earlyNCT01723813What this trial is testingPeptide Vaccinations Plus GM-CT-01 in MelanomaWho this might be right forMetastatic Melanoma Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Early research (Phase 1)Study completedNCT01107418What this trial is testingA Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT00334776What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) University of Southern California 6
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Testing effectiveness (Phase 2)Study completedNCT02259231What this trial is testingRTA 408 Capsules in Patients With Melanoma - REVEALWho this might be right forMelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma Biogen 41
Testing effectiveness (Phase 2)Study completedNCT02379195What this trial is testingPeginterferon and TIL Therapy for Metastatic MelanomaWho this might be right forMetastatic Melanoma Inge Marie Svane 12
Testing effectiveness (Phase 2)Ended earlyNCT03009058What this trial is testingStudy of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable CancerWho this might be right forMetastatic Cancer Immodulon Therapeutics Ltd 2
Early research (Phase 1)Ended earlyNCT01611675What this trial is testingLeflunomide+Vemurafenib in V600 Mutant Met. MelanomaWho this might be right forMelanoma Massachusetts General Hospital 3
Testing effectiveness (Phase 2)Looking for participantsNCT06070012What this trial is testingTebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal MelanomaWho this might be right forUveal Melanoma Diwakar Davar 44
Testing effectiveness (Phase 2)Study completedNCT00121225What this trial is testingVorinostat in Treating Patients With Metastatic or Unresectable MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT04526899What this trial is testingInvestigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of TreatmentWho this might be right forMelanoma Stage IIIMelanoma Stage IVUnresectable Melanoma BioNTech SE 184
Early research (Phase 1)Study completedNCT02457793What this trial is testingThe Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forNon-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, Melanoma Genentech, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT02771626What this trial is testingStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)Who this might be right forClear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Study completedNCT00587964What this trial is testingPhase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesWho this might be right forBrain MetastasisBladder CancerBreast Cancer+10 more Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT00004135What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) University of Chicago 19